Where does Aquestive Therapeutics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Aquestive Therapeutics, Inc. ranks #12,808 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Aquestive Therapeutics, Inc. hold?

Aquestive Therapeutics, Inc. holds 23 US utility patents granted between 2018 and 2025, spanning 18 technology areas.

What is Aquestive Therapeutics, Inc.'s Innovation Score?

Aquestive Therapeutics, Inc. has an Innovation Score of 42.2 out of 100 (top 31% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Aquestive Therapeutics, Inc. focus on?

Aquestive Therapeutics, Inc.'s top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 17 patents, ranking #1,331 of 7,163 assignees active in that subclass. Grants appear in 18 CPC subclasses total.

Is Aquestive Therapeutics, Inc.'s patent grant rate increasing or decreasing?

Aquestive Therapeutics, Inc.'s recent grant velocity is +275% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Aquestive Therapeutics, Inc.'s patents?

Aquestive Therapeutics, Inc.'s patents average 22.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Aquestive Therapeutics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Aquestive Therapeutics, Inc.

USPTO PatentsView assignee record - 23 granted patents across 18 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Aquestive ranks #12,808 of 49,997 tracked US assignees by granted-patent volume, with 23 patents across 18 technology areas.

#12,808
of 49,997 US assignees by volume: Top 31%
by Innovation Score (42.2/100): 22.4
avg claims per patent: +275%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R12808 · US Corporation #12,808 · 23 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 23 grants
MID-PACK #12,808/49,997
PHOTO-FINISH American University…
CPC-FOCUS A61K · 18 areas
INNOV-PAR 42.2/100
CLAIMS-DENSE 22.4 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +275% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: American University of Beirut (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Aquestive’s 42.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.0 pts (26%) Velocity 2.8 pts (7%) Breadth 15.0 pts (36%) Claim depth 13.4 pts (32%)

Qualcomm Incorporated · highest

85
Aquestive Therapeutics · this assignee

42
3D Lighting… · lowest

7

What this shows Aquestive's Innovation Score is 42.2/100 (top 31% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Aquestive?

Each dot is one of Aquestive’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Aquestive’s own 22.4 claims/patent is ABOVE the 14.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Aquestive vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Aquestive's grants concentrate

Aquestive Therapeutics, Inc. is a focused PatentsView assignee: 18 CPC subclasses with 73.9% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2021 (8 grants) versus a trough of 1 in 2022. By volume, Aquestive sits between American University of Beirut and AstraZeneca UK Limited.

Aquestive's three-year grant acceleration

Aquestive Therapeutics, Inc. shows 5 grants in 2022–2024 against only 12 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

American Universi…

23
Ankh Life Sciences

23
Aperia

23
Apstra

23
Armada Systems

23
Artsana USA

23
Aruze Gaming (Hon…

23
Astrazeneca UK

23
Aquestive Therape… ◀

23

What this shows Aquestive holds 23 patents at rank #12,814, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Aquestive

By rank, the assignees closest to #12,814 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Aquestive's primary technology class.

Aquestive's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

42 Top 31% higher than 69% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

Aquestive Therapeutics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	2	8.7%
2019	2	8.7%
2020	2	8.7%
2021	8	34.8%
2022	1	4.3%
2023	2	8.7%
2024	2	8.7%
2025partial year	4	17.4%

Which technologies does Aquestive Therapeutics, Inc. patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 17

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 12

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 9

Y02A - Technologies FOR Adaptation TO Climate Change 6

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 6

B65B - Machines, Apparatus OR Devices FOR, OR Methods OF, Packaging Articles OR MATERIALS; Unpacking 4

B29K - Indexing Scheme Associated With Subclasses B29b, B29c OR B29d, Relating TO Moulding Materials OR TO Materials FOR ; Moulds, ; Reinforcements, Fillers OR Preformed Parts, e.g. Inserts 4

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 3

B29L - Indexing Scheme Associated With Subclass B29c, Relating TO Particular Articles 2

C08J - WORKING-UP; General Processes OF COMPOUNDING; After-treatment NOT Covered BY Subclasses C08b, C08c, C08f, C08g or C08h 2

F26B - Drying Solid Materials OR Objects BY Removing Liquid Therefrom 2

B32B - Layered Products, i.e. Products Built-up OF Strata OF Flat OR Non-flat, e.g. Cellular OR Honeycomb, Form 2

B65D - Containers FOR Storage OR Transport OF Articles OR Materials, e.g. Bags, Barrels, Bottles, Boxes, Cans, Cartons, Crates, Drums, Jars, Tanks, Hoppers, Forwarding CONTAINERS; Accessories, Closures, OR Fittings THEREFOR; Packaging ELEMENTS; Packages 2

Y10T - Technical Subjects Covered BY Former US Classification 2

A23L - Foods, Foodstuffs OR Non-alcoholic Beverages, NOT Otherwise Provided FOR; Preparation OR Treatment Thereof 1

Top 15 of 18 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Aquestive Therapeutics, Inc.'s patent record in context - here's where to go next.

Aquestive Therapeutics, Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 73.9% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #12,808 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Aquestive Therapeutics, Inc. against American University of Beirut, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 42.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.